Our Sites » TechNews TechDatabase Canadian Private Equity Register     Login

Home » People » Cardiome Pharma replaces CEO Doug Janzen

Cardiome Pharma replaces CEO Doug Janzen

Cardiome Pharma Corp. (NASDAQ: CRME; TSX: COM) disclosed that Douglas G. Janzen, its CEO, has left the company effective immediately. Dr. William Hunter, a director of Cardiome Pharma, has been appointed interim CEO. Janzen... 

To Read This Article, please Login





See Also:

Copyright © 2013 TechFinance.ca. All rights reserved. | Healthy Living | wp-tips.
More in People (18 of 348 articles)


...